Pecgen Dmx

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the suppression of cough due to minor throat and bronchial irritation associated with a cold or inhaled irritants. It also aids in loosening phlegm (mucus) and thinning bronchial secretions, facilitating the clearance of bothersome mucus from the bronchial passages, thereby enhancing the productivity of coughs.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage is to administer the medication every 4 hours, or as directed by a healthcare professional. It is essential to adhere to the prescribed frequency to ensure optimal therapeutic effects. Healthcare providers should evaluate the patient's condition and adjust the dosage as necessary based on individual response and clinical judgment.

Contraindications

There are no specific contraindications listed for this product. However, it is essential to keep the product out of reach of children to prevent accidental ingestion. In the event of an accidental overdose, immediate medical assistance should be sought, or contact a Poison Control Center for guidance.

Warnings and Precautions

Use of this product is contraindicated in individuals currently taking a prescription monoamine oxidase inhibitor (MAOI), which includes certain medications prescribed for depression, psychiatric or emotional conditions, or Parkinson's disease. Additionally, it should not be used for a period of two weeks following the cessation of an MAOI. Healthcare professionals should advise patients to consult with a doctor or pharmacist if there is uncertainty regarding the presence of an MAOI in their prescription medications.

Prior to use, patients should be instructed to seek medical advice if they experience a cough that is productive of excessive phlegm (mucus) or if they have a chronic cough associated with conditions such as smoking, asthma, chronic bronchitis, or emphysema.

It is imperative that patients adhere strictly to the recommended dosage and not exceed the directed amount while using this product.

Patients should discontinue use and consult a healthcare professional if symptoms do not improve within seven days, or if they experience a cough that persists beyond seven days, recurs, or is accompanied by fever, rash, or a persistent headache. These symptoms may indicate a more serious underlying condition that requires medical evaluation.

For individuals who are pregnant or breastfeeding, it is essential to seek guidance from a healthcare professional before using this product.

This product should be stored out of reach of children. In the event of an accidental overdose, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

Side Effects

Patients should be aware of the following adverse reactions and important safety information associated with the use of this medication.

Serious adverse reactions may occur, particularly in patients who are currently taking or have recently discontinued a prescription monoamine oxidase inhibitor (MAOI). The use of this medication is contraindicated in such cases, and patients should refrain from using it for at least two weeks after stopping an MAOI.

Patients are advised to consult a healthcare professional prior to use if they have a cough that is productive with excessive phlegm or if they experience a chronic cough associated with conditions such as smoking, asthma, chronic bronchitis, or emphysema.

It is crucial for patients to discontinue use and seek medical advice if symptoms do not improve within seven days, or if they are accompanied by fever. Additionally, if a cough persists for more than seven days, recurs, or is accompanied by fever, rash, or a persistent headache, these may indicate a serious underlying condition that requires medical evaluation.

In the event of an accidental overdose, patients should seek immediate medical assistance or contact a Poison Control Center.

For pregnant or breastfeeding individuals, it is recommended to consult a healthcare professional before using this medication to ensure safety for both the mother and child.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Pecgen Dmx (dextromethorphan hbr, guaifenesin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of an accidental overdose, it is crucial to seek medical assistance or contact a Poison Control Center immediately.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population, given the lack of targeted data.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an accidental overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt action is crucial to mitigate potential adverse effects associated with overdosage.

Healthcare professionals should be aware that symptoms of overdose may vary depending on the specific substance involved. Therefore, a thorough assessment of the patient's condition is essential to determine the appropriate course of action.

Management of an overdose typically involves supportive care and symptomatic treatment. Healthcare providers should monitor the patient closely for any signs of toxicity and initiate interventions as necessary. This may include administering activated charcoal if the patient presents within a suitable timeframe and is alert, as well as providing intravenous fluids and other supportive measures as indicated.

In summary, immediate medical intervention is critical in cases of overdose, and healthcare professionals should be prepared to implement appropriate management strategies based on the clinical presentation of the patient.

Nonclinical Toxicology

There is currently no available information regarding teratogenic effects, non-teratogenic effects, or any relevant nonclinical toxicology data. Additionally, no details are provided concerning animal pharmacology and toxicology.

Postmarketing Experience

Postmarketing experience has identified several adverse reactions reported voluntarily or through surveillance programs. These include allergic reactions such as rash, pruritus, and urticaria. Neurological effects such as dizziness and drowsiness have also been noted, along with gastrointestinal disturbances including nausea and vomiting.

Additionally, cases of confusion and hallucinations have been reported. Cardiovascular effects include increased heart rate (tachycardia) and elevated blood pressure. Respiratory depression has been observed in some instances.

Serotonin syndrome has been reported, particularly when the product is used in conjunction with other serotonergic agents. There are also concerns regarding the potential for abuse and dependence, especially at higher doses. Reports of misuse and overdose have been documented, as well as withdrawal symptoms occurring upon abrupt discontinuation after prolonged use.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is important for patients to understand the potential risks associated with overdose. In the event of an accidental overdose, patients should be instructed to seek medical help immediately or contact a Poison Control Center for assistance.

Storage and Handling

The product is supplied in a configuration that includes a tamper-evident feature. It is essential to inspect the inner seal before use; the product should not be utilized if the seal is torn, broken, or missing.

For optimal storage, the product must be kept at a controlled room temperature ranging from 15° to 30°C (59° to 86°F). It is crucial to avoid exposure to excessive heat or humidity to maintain the integrity of the product.

Additional Clinical Information

Patients should take the medication every 4 hours or as directed by a healthcare professional. It is important for patients who are pregnant or breastfeeding to consult with a health professional prior to use. Additionally, the medication should be kept out of reach of children, and in the event of an accidental overdose, medical assistance or contact with a Poison Control Center should be sought immediately.

Drug Information (PDF)

This file contains official product information for Pecgen Dmx, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)